Danaher Sees Q4 2026 Non-GAAP Core Revenue Excluding Respiratory Revenue Up 4%-5% YoY

Danaher (NYSE: DHR) anticipates that its non-GAAP core revenue for the fourth quarter of 2026, excluding respiratory revenue, will rise by 4.0% to 5.0% compared to the previous year.